Skip to content
JournalsWorldThe Global Research Discovery Platform
Login Sign Up

Academic Journal

Q1

PPAR Research

John Wiley and Sons Ltd

United KingdomDrug Discovery (Q1); Pharmacology (medical) (Q1)ISSN-matched source record
Submission information ↗
Q1Ranking
—Impact Factor (year unverified)
65H-index (SCImago 2025)
1SJR (2025)
2006-2026Coverage

About PPAR Research

PPAR Research is a scholarly journal published by John Wiley and Sons Ltd. SCImago 2025 lists it in Q1, with an SJR of 1 and H-index of 65.

Coverage: 2006-2026. Research categories: Drug Discovery (Q1); Pharmacology (medical) (Q1).

Open-access policies and author information

Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-03-12. This snapshot does not establish today’s listing status or fee quotation.

Accepted manuscript languagesEnglish
Licence optionsCC BY
Peer-review processAnonymous peer review
APCDOAJ-reported APC: 1790 USD; 1200 GBP; 1550 EUR
Waiver policy reportedYes
Other fees reportedNo
Author retains unrestricted copyrightYes
Digital preservationPMC, Portico, CLOCKSS
Reported submission-to-publication time12 weeks on average; not a guarantee
Openly licensed content since2006 (not the journal founding year)

Publisher policy links recorded by DOAJ

Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.

Source-backed journal facts

ISSN(s)1687-4757, 1687-4765
ISSN-L1687-4757
Source typeJournal
Publisher / hosting organisationHindawi Publishing Corporation
Publisher country codeGB
Fully open access (OpenAlex)Yes
DOAJ flag (OpenAlex)Listed in OpenAlex metadata; confirm current status in DOAJ
Works recorded in OpenAlex689
Citations recorded in OpenAlex23,937
OpenAlex H-index72
Years represented in OpenAlex1965–2026 (not the founding or closing dates)

Topics in published research

Peroxisome Proliferator-Activated Receptors; Adipose Tissue and Metabolism; Metabolism, Diabetes, and Cancer; Cancer, Lipids, and Metabolism; Eicosanoids and Hypertension Pharmacology; Inflammatory mediators and NSAID effects.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit